Industry News - China Isotope Development

Enriched Gd-160 Target Materials: Pioneering Dual-Purpose Cancer Imaging and Treatment

Industry NewsBy China Isotope Development 2025-12-28

Enriched Gd-160 Target Materials: Pioneering Dual-Purpose Cancer Imaging and Treatment BY Tao, Published Dec 28, 2025 Enriched Gadolinium‑160 (Gd‑160) is not administered to patients—it is a stable “target material” placed in a reactor to manufacture Terbium‑161 (Tb‑161), one of the most compelling next-generation radionuclides for precision cancer theranostics (therapy + imaging in one platform). The strategic value of enriched Gd‑160…

The Strategic Role of Gd-160 in Manufacturing Terbium-161 for Precision Cancer Treatment

Industry NewsBy China Isotope Development 2025-12-28

The Strategic Role of Gd-160 in Manufacturing Terbium-161 for Precision Cancer Treatment BY Tao, Published Dec 28, 2025 The landscape of targeted radionuclide therapy is undergoing a transformative shift. After more than two decades immersed in isotope research and production, Terbium-161 (Tb-161) represents something genuinely exceptional—a therapeutic radionuclide that may fundamentally enhance how we approach…

Gadolinium-160 Target Material: A Game-Changer for Next-Generation Beta Therapy in Oncology

Industry NewsBy China Isotope Development 2025-12-28

Gadolinium-160 Target Material: A Game-Changer for Next-Generation Beta Therapy in Oncology BY Tao, Published Dec 28, 2025 Gadolinium-160 (Gd-160) is not a “therapy isotope” itself—it is a strategic stable target material that enables reliable reactor production of Terbium-161 (Tb-161), one of the most compelling next-generation radionuclides for targeted beta therapy and theranostics (therapy + imaging) in oncology. What makes this pathway special…

From Gd-160 to Tb-161: Revolutionizing Theranostic Applications in Nuclear Medicine

Industry NewsBy China Isotope Development 2025-12-28

From Gd-160 to Tb-161: Revolutionizing Theranostic Applications in Nuclear Medicine BY Tao, Published Dec 28, 2025 From the early days of Iodine-131 to the recent dominance of Lutetium-177 (177Lu177Lu), each generation of isotopes has pushed the boundaries of what is clinically possible. However, as we stand here in late 2025, reflecting on the…

Gadolinium-160: The Essential Precursor for Terbium-161 Production in Targeted Cancer Radiotherapy

Industry NewsBy China Isotope Development 2025-12-28

Gadolinium-160: The Essential Precursor for Terbium-161 Production in Targeted Cancer Radiotherapy BY Tao, Published Dec 28, 2025 Terbium-161 (Tb-161) is emerging as one of the most promising “next-step” therapeutic radionuclides for targeted radionuclide therapy (also called targeted radiotherapy or radioligand therapy) because it behaves chemically like the widely used Lutetium-177 (Lu-177), yet delivers additional ultra-short-range electron dose that…

Unlocking Precision: How Nickel-64 Serves as the Key Precursor for Cancer-Targeting Copper-64

Industry NewsBy China Isotope Development 2025-12-14

Unlocking Precision: How Nickel-64 Serves as the Key Precursor for Cancer-Targeting Copper-64 BY Tao, Published Dec 14, 2025 With more enquiries on Nickel-64 Isotope from web, I would like to share my production experience and operation these year to more end users who are interested. I have witnessed firsthand how the careful selection…

Zinc-68 Isotope: The High-Abundance Stable Target Material Leading the Revolution in Next-Generation Medical Radionuclide Production

Industry NewsBy China Isotope Development 2025-12-14

Zinc-68 Isotope: The High-Abundance Stable Target Material Leading the Revolution in Next-Generation Medical Radionuclide Production BY Tao, Published Dec 14, 2025 With more enquiries on Zinc-68 Isotope from web, I would like to share my production experience and operation these year to more end users who are interested. As a nuclear staff with more…

Research Report: R245fa (HFC-245fa) – China’s 2026 Quota Release

Industry NewsBy China Isotope Development 2025-12-11

Research Report: R245fa (HFC-245fa) – China’s 2026 Quota Release BY Tao, Published Dec 11, 2025 R245fa (1,1,1,3,3-pentafluoropropane), a third-generation hydrofluorocarbon (HFC), serves primarily as a blowing agent in rigid polyurethane (PU) foam insulation. It has gained prominence as a substitute for the phased-out second-generation refrigerant HCFC-141b. Recent policy developments in China, the world’s…

Ultra High Purity Nitrogen Supply for Semiconductor Factories: Core Requirements and something you need to know

Industry NewsBy China Isotope Development 2025-12-07

Ultra High Purity Nitrogen Supply for Semiconductor Factories: Core Requirements and something you need to know BY Tao, Published Dec 7, 2025 Ultra High Purity Nitrogen (N₂), as the most widely used “electronic specialty gas” in semiconductor manufacturing, is widely applied throughout the entire process, including wafer cleaning, photolithography, etching, deposition, packaging, and testing, due…

Trifluormethanesulfonic Anhydride(Tf2O): Essential Catalyst for Peptide Protection and Tamiflu-Like Drug Development

Industry NewsBy China Isotope Development 2025-12-03

Trifluormethanesulfonic Anhydride(Tf2O): Essential Catalyst for Peptide Protection and Tamiflu-Like Drug Development BY Tao, Published Dec 3, 2025 Introduction: The Hidden Engine of Modern Pharmaceuticals In my thirty years navigating the complex landscape of fluorochemistry, I have witnessed the evolution of pharmaceutical synthesis from a process of trial-and-error to an era of atomic precision. Among…